{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:41:30Z","timestamp":1761709290737},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbamcr.2016.12.020","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T20:02:28Z","timestamp":1482350548000},"page":"572-579","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Outside in: The matrix as a modifier of muscular dystrophy"],"prefix":"10.1016","volume":"1864","author":[{"given":"Mattia","family":"Quattrocelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2016.12.020_bb0005","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population","volume":"132","author":"Norwood","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ejhg.2012.269","article-title":"Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age","volume":"21","author":"Mercier","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0025","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/humu.21114","article-title":"Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort","volume":"30","author":"Flanigan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejpn.2011.07.001","article-title":"Motor and respiratory heterogeneity in Duchenne patients: implication for clinical trials","volume":"16","author":"Humbertclaude","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nmd.2014.06.003","article-title":"Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin","volume":"24","author":"Zatz","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0045","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0055","doi-asserted-by":"crossref","first-page":"e0150748","DOI":"10.1371\/journal.pone.0150748","article-title":"The mdx mutation in the 129\/Sv background results in a milder phenotype: transcriptome comparative analysis searching for the protective factors","volume":"11","author":"Calyjur","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0060","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/WCO.0000000000000240","article-title":"Modifier genes and their effect on Duchenne muscular dystrophy","volume":"28","author":"Vo","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0065","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1093\/hmg\/ddu413","article-title":"Myofiber-specific inhibition of TGFbeta signaling protects skeletal muscle from injury and dystrophic disease in mice","volume":"23","author":"Accornero","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0070","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI37662","article-title":"Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta","volume":"119","author":"Vetrone","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0075","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2015.10.049","article-title":"Jagged 1 rescues the Duchenne muscular dystrophy phenotype","volume":"163","author":"Vieira","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0080","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1083\/jcb.142.5.1279","article-title":"Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin","volume":"142","author":"Hack","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0085","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1172\/JCI39845","article-title":"Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice","volume":"119","author":"Heydemann","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0090","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1073\/pnas.1324242111","article-title":"Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair","volume":"111","author":"Swaggart","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0095","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1083\/jcb.151.6.1321","article-title":"Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology","volume":"151","author":"Chen","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0100","doi-asserted-by":"crossref","first-page":"15000","DOI":"10.1073\/pnas.192571199","article-title":"Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle","volume":"99","author":"Haslett","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0925-4439(99)00084-8","article-title":"Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse","volume":"1500","author":"Tkatchenko","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/hmg\/11.3.263","article-title":"A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice","volume":"11","author":"Porter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1096\/fj.05-4678fje","article-title":"Common pathological mechanisms in mouse models for muscular dystrophies","volume":"20","author":"Turk","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/pr.2015.257","article-title":"Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac\/skeletal muscle function in Duchenne muscular dystrophy","volume":"79","author":"Galindo","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2559.2011.04051.x","article-title":"Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis","volume":"59","author":"Zanotti","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.0b013e318207afeb","article-title":"SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy","volume":"76","author":"Pegoraro","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1212\/WNL.0b013e31825f04ea","article-title":"Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy","volume":"79","author":"Bello","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0140","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.24370","article-title":"Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study","volume":"77","author":"Bello","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0145","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp-2014-308409","article-title":"Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants","volume":"86","author":"van den Bergen","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1083\/jcb.201510086","article-title":"Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype","volume":"213","author":"Capote","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0155","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.biocel.2008.03.020","article-title":"Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro","volume":"40","author":"Uaesoontrachoon","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1242\/dmm.009993","article-title":"Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury","volume":"6","author":"Uaesoontrachoon","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physiolgenomics.00138.2004","article-title":"Polymorphisms in the osteopontin promoter affect its transcriptional activity","volume":"20","author":"Giacopelli","year":"2004","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0945-053X(00)00108-6","article-title":"Osteopontin: a versatile regulator of inflammation and biomineralization","volume":"19","author":"Giachelli","year":"2000","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/path.4026","article-title":"TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle","volume":"228","author":"Piva","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0180","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddu118","article-title":"Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage","volume":"23","author":"Barfield","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0185","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1038\/sj.onc.1203917","article-title":"Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0190","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/onc.2014.410","article-title":"Osteopontin mediates an MZF1-TGF-beta1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer","volume":"34","author":"Weber","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/excr.2000.5074","article-title":"TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements","volume":"262","author":"Hullinger","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0200","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0006-291X(89)90837-1","article-title":"Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta","volume":"162","author":"Kubota","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0205","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ajhg.2016.08.023","article-title":"Association study of exon variants in the NF-kappaB and TGFbeta pathways identifies CD40 as a modifier of Duchenne muscular dystrophy","volume":"99","author":"Bello","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0014-5793(97)00685-6","article-title":"Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-beta binding proteins","volume":"411","author":"Giltay","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0220","doi-asserted-by":"crossref","first-page":"e0141240","DOI":"10.1371\/journal.pone.0141240","article-title":"Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy","volume":"10","author":"Barp","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0225","doi-asserted-by":"crossref","first-page":"e0150358","DOI":"10.1371\/journal.pone.0150358","article-title":"Genotype-specific interaction of latent TGFbeta binding protein 4 with TGFbeta","volume":"11","author":"Lamar","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0230","doi-asserted-by":"crossref","first-page":"e1006019","DOI":"10.1371\/journal.pgen.1006019","article-title":"Overexpression of latent TGFbeta binding protein 4 in muscle ameliorates muscular dystrophy through myostatin and TGFbeta","volume":"12","author":"Lamar","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0235","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/physiolgenomics.00056.2003","article-title":"Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration","volume":"14","author":"Goetsch","year":"2003","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1083\/jcb.201402079","article-title":"Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy","volume":"207","author":"Dadgar","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1083\/jcb.201105013","article-title":"PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy","volume":"196","author":"Ardite","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0255","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1073\/pnas.1204708109","article-title":"Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway","volume":"109","author":"Lorts","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0260","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcp.1041330319","article-title":"Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta","volume":"133","author":"Allen","year":"1987","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0265","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0270","doi-asserted-by":"crossref","first-page":"e5205","DOI":"10.1371\/journal.pone.0005205","article-title":"Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells","volume":"4","author":"Gnocchi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0275","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1126\/science.1087573","article-title":"Notch-mediated restoration of regenerative potential to aged muscle","volume":"302","author":"Conboy","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-213X-14-2","article-title":"Distinct contextual roles for Notch signalling in skeletal muscle stem cells","volume":"14","author":"Mourikis","year":"2014","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.1110364","article-title":"Bone marrow stromal cells generate muscle cells and repair muscle degeneration","volume":"309","author":"Dezawa","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0290","doi-asserted-by":"crossref","first-page":"e1448","DOI":"10.1038\/cddis.2014.401","article-title":"Notch signaling regulates myogenic regenerative capacity of murine and human mesoangioblasts","volume":"5","author":"Quattrocelli","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0295","doi-asserted-by":"crossref","first-page":"e63896","DOI":"10.1371\/journal.pone.0063896","article-title":"Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-beta\/Smad3 signaling","volume":"8","author":"Sassoli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0300","first-page":"522","article-title":"Notch prevents transforming growth factor-beta-assisted epithelial-mesenchymal transition in cultured limbal progenitor cells through the induction of Smad7","volume":"20","author":"Tsai","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0305","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nbt.3557","article-title":"No longer going to waste","volume":"34","author":"Garber","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2006.03.005","article-title":"Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy","volume":"175","author":"Andreetta","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0315","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0320","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/labinvest.2012.78","article-title":"An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy","volume":"92","author":"Ohsawa","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0325","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0330","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional improvement of dystrophic muscle by myostatin blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0335","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13395-016-0085-7","article-title":"Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures","volume":"6","author":"Kornegay","year":"2016","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0340","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1073\/pnas.0707069105","article-title":"Tendons of myostatin-deficient mice are small, brittle, and hypocellular","volume":"105","author":"Mendias","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0345","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0350","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ajpath.2010.11.071","article-title":"Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy","volume":"178","author":"Pistilli","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0355","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13395-016-0098-2","article-title":"ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments","volume":"6","author":"Hatakeyama","year":"2016","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0360","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of sporadic inclusion body myositis with bimagrumab","volume":"83","author":"Amato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0365","author":"MorphoSysAG"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0370","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study","volume":"85","author":"Bello","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0375","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy","volume":"84","author":"Ricotti","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.23808","volume":"48","author":"Henricson","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0385","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1067\/mpd.2001.109601","article-title":"Deflazacort treatment of Duchenne muscular dystrophy","volume":"138","author":"Biggar","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0390","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.880170405","article-title":"Deflazacort in Duchenne dystrophy: study of long-term effect","volume":"17","author":"Angelini","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0395","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/WNL.41.12.1874","article-title":"Long-term benefit from prednisone therapy in Duchenne muscular dystrophy","volume":"41","author":"Fenichel","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0400","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jpeds.2013.05.060","article-title":"Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy","volume":"163","author":"Barber","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0405","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","article-title":"Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy","volume":"18","author":"Markham","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0410","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9149(02)03429-X","article-title":"Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy","volume":"91","author":"Silversides","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0415","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/01.JIM.0000446835.98223.ce","article-title":"Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies","volume":"62","author":"Hussein","year":"2014","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0420","doi-asserted-by":"crossref","first-page":"e88360","DOI":"10.1371\/journal.pone.0088360","article-title":"Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy","volume":"9","author":"Janssen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0425","doi-asserted-by":"crossref","first-page":"e11220","DOI":"10.1371\/journal.pone.0011220","article-title":"Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy","volume":"5","author":"Guerron","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0430","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/hmg\/ddu033","article-title":"Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy","volume":"23","author":"Uaesoontrachoon","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0435","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/1097-4598(200103)24:3<428::AID-MUS1018>3.0.CO;2-E","article-title":"Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice","volume":"24","author":"Hartel","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0440","doi-asserted-by":"crossref","first-page":"e0156225","DOI":"10.1371\/journal.pone.0156225","article-title":"Glucocorticoids enhance muscle proteolysis through a myostatin-dependent pathway at the early stage","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.020_bb0445","author":"P.P.M.D."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488916303457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488916303457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T18:23:41Z","timestamp":1536171821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488916303457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0167488916303457"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.12.020","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outside in: The matrix as a modifier of muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}